The diabetic neuropathic pain market is expanding due to increased prevalence of diabetes, rising adoption of gabapentin, pregabalin, SNRIs, topical agents, and neuromodulation devices for managing chronic nerve pain. https://www.datamintelligence.com/research-report/diabetic-neuropathic-pain-market